Forgot your password?
New user?
Nanoparticle fear over anti-odour socks
Fragment-based Lead Discovery Conference 2008
test conference
Document Actions
Combination Drug Therapies
| Type | Conference |
|---|---|
| Date |
April 13, 2010
to April 14, 2010 |
| Venue |
Sheraton Philadelphia Center City 17th and Race Street Philadelphia, PA 19103 US |
| Chemistry Specialties |
|
| Chemistry Techniques |
|
| Contact |
Kris Waterman Cambridge Healthtech Institute 250 First Ave Needham, MA 02494 US 781-972-5400 781-972-5425 chi@healthtech.com |
| Add event to calendar |
vCal (Windows, Linux)
iCal (Mac OS X)
|
Fixed-Dose and Co-Packaged Combinations provide novel business opportunities for companies to leverage their existing portfolio of products and intellectual property in addition to providing avenues for strategic partnership with other companies. However, they also offer unique development, regulatory, and commercial challenges. This conference will focus on the practical interplay between combination therapy forefront research, development challenges, and commercial and partnering strategies, as well as the implications for successful market realization.
Sponsors
Cambridge Healthtech Institute
Session titles
Determining the Commercial Scope for Combination Therapies in Particular Therapeutic Areas;
Achieving Innovative Line Extension and Life-Cycle Management (LCM) Strategies;
Intellectual Property Leveraging, Licensing, and Protection;
Overcoming Development and Formulation Challenges of Combination Therapies;
Emerging Therapeutic Areas for Combinations: Performance to Date and Future Prospects;
Understanding Regulatory Hurdles and Variation in International Acceptance